Vimarsana
Biggest News Aggregation in the World

Precision Diabetes News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Precision Diabetes. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Precision Diabetes Today - Breaking & Trending Today

New Clinical Data Point to Use of GlycoMark as Biomarker of SGLT-2 Diabetes Drug Effectiveness and Compliance - Vimarsana News

New Clinical Data Point to Use of GlycoMark as Biomarker of SGLT-2 Diabetes Drug Effectiveness and Compliance

RALEIGH, N.C., Oct. 30, 2023 /PRNewswire/ -- Precision Diabetes, Inc. announces new studies that show that the GlycoMark blood test, which measures

New Study Shows GlycoMark® Test Identifies Prediabetic Individuals with the Highest Risk of Developing Diabetes Before Symptoms Develop - Vimarsana News

New Study Shows GlycoMark® Test Identifies Prediabetic Individuals with the Highest Risk of Developing Diabetes Before Symptoms Develop

/PRNewswire/ -- A new study indicates that the GlycoMark blood test identifies high-risk, asymptomatic patients with prediabetes, not detected by standard...

New Study Shows Critical Role of 1,5-Anhydroglucitol (1,5-AG) in COVID-19 Pathogenesis by Binding to the COVID-19 Spike Protein - Vimarsana News

New Study Shows Critical Role of 1,5-Anhydroglucitol (1,5-AG) in COVID-19 Pathogenesis by Binding to the COVID-19 Spike Protein

/PRNewswire/ -- Precision Diabetes, Inc. A new study recently published in Nature Metabolism shows that 1,5-anhydroglucitol (1,5-AG), a glucose-like...

Precision Diabetes, Inc. (PDI) Presents Data on Precision IGT Prediabetes Test at Precision Diabetes Medicine 2021 Conference - Vimarsana News

Precision Diabetes, Inc. (PDI) Presents Data on Precision IGT Prediabetes Test at Precision Diabetes Medicine 2021 Conference

Share this article Share this article RALEIGH, N.C., April 15, 2021 /PRNewswire/ -- Precision Diabetes, Inc. (PDI), an emerging leader in precision diabetes diagnostics, announced results today from a study on its Precision IGT prediabetes test at the Precision Diabetes Medicine 2021 Conference, the annual research symposium of the Precision Medicine in Diabetes Initiative (PMDI) -- a joint effort of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). The study, "Serum Alpha-Hydroxybutyrate (AHB) Predicts Elevated 1-Hour Glucose Levels in No...